A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt.
BACKGROUND
Information on factors that influence parental decisions for actual human papillomavirus (HPV) vaccine receipt in publicly funded, school-based HPV vaccine programs for girls is limited. We report on the level of uptake of the first dose of the HPV vaccine, and determine parental factors associated with receipt of the HPV vaccine, in a publicly funded school-based HPV vaccine program in British Columbia, Canada.


RESULTS
All parents of girls enrolled in grade 6 during the academic year of September 2008-June 2009 in the province of British Columbia were eligible to participate. Eligible households identified through the provincial public health information system were randomly selected and those who consented completed a validated survey exploring factors associated with HPV vaccine uptake. Bivariate and multivariate analyses were conducted to calculate adjusted odds ratios to identify the factors that were associated with parents' decision to vaccinate their daughter(s) against HPV. 2,025 parents agreed to complete the survey, and 65.1% (95% confidence interval [CI] 63.1-67.1) of parents in the survey reported that their daughters received the first dose of the HPV vaccine. In the same school-based vaccine program, 88.4% (95% CI 87.1-89.7) consented to the hepatitis B vaccine, and 86.5% (95% CI 85.1-87.9) consented to the meningococcal C vaccine. The main reasons for having a daughter receive the HPV vaccine were the effectiveness of the vaccine (47.9%), advice from a physician (8.7%), and concerns about daughter's health (8.4%). The main reasons for not having a daughter receive the HPV vaccine were concerns about HPV vaccine safety (29.2%), preference to wait until the daughter is older (15.6%), and not enough information to make an informed decision (12.6%). In multivariate analysis, overall attitudes to vaccines, the impact of the HPV vaccine on sexual practices, and childhood vaccine history were predictive of parents having a daughter receive the HPV vaccine in a publicly funded school-based HPV vaccine program. By contrast, having a family with two parents, having three or more children, and having more education was associated with a decreased likelihood of having a daughter receive the HPV vaccine.


CONCLUSIONS
This study is, to our knowledge, one of the first population-based assessments of factors associated with HPV vaccine uptake in a publicly funded school-based program worldwide. Policy makers need to consider that even with the removal of financial and health care barriers, parents, who are key decision makers in the uptake of this vaccine, are still hesitant to have their daughters receive the HPV vaccine, and strategies to ensure optimal HPV vaccine uptake need to be employed.
Ogilvie
Gina
G
University of British Columbia, Vancouver, Canada. gina.ogilvie@bccdc.ca
Anderson
Maureen
M
Marra
Fawziah
F
McNeil
Shelly
S
Pielak
Karen
K
Dawar
Meena
M
McIvor
Marilyn
M
Ehlen
Thomas
T
Dobson
Simon
S
Money
Deborah
D
Patrick
David M
DM
Naus
Monika
M
D000328:Adult; D001294:Attitude to Health; D001955:British Columbia; D002648:Child; D003657:Decision Making; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000517:prevention & control* / Q000523:psychology; D053918:Papillomavirus Vaccines; D010290:Parents; D010342:Patient Acceptance of Health Care; D015397:Program Evaluation; D012574:Schools; D012959:Socioeconomic Factors; D014611:Vaccination / Q000523:psychology* / Q000706:statistics & numerical data; D055815:Young Adult
D053918:Papillomavirus Vaccines
Pediatrics. 2006 May;117(5):1486-93
16651301
Lancet. 2007 Jun 2;369(9576):1861-1868
17544766
J Adolesc Health. 2007 Feb;40(2):108-15
17259050
Vaccine. 2007 Mar 1;25(11):1945-52
17284337
J Adolesc Health. 2007 May;40(5):466-9
17448408
J Adolesc Health. 2005 Sep;37(3):248-51
16109349
Lancet. 2007 Jun 30;369(9580):2161-2170
17602732
BMJ. 2008 May 10;336(7652):1056-8
18436917
Soc Sci Med. 2007 Oct;65(8):1765-72
17643686
N Engl J Med. 2009 May 7;360(19):1981-8
19420367
J Pathol. 1999 Sep;189(1):12-9
10451482
J Adolesc Health. 2008 Sep;43(3):239-45
18710678
J Low Genit Tract Dis. 2004 Jul;8(3):188-94
15874862
J Infect Dis. 2008 Jun 15;197(12):1653-61
18513154
Can J Hum Sex. 2008 Jan 1;17(1-2):1-13
23115485
J Adolesc Health. 2009 May;44(5):437-45
19380090
Vaccine. 2006 Aug 31;24 Suppl 3:S3/164-70
16950004
Lancet. 2007 May 19;369(9574):1693-702
17512854
Vaccine. 2006 Aug 31;24 Suppl 3:S3/178-86
16950005
Public Health Nurs. 2008 Sep-Oct;25(5):401-8
18816357
J Adolesc Health. 2005 Dec;37(6 Suppl):S17-23
16310137
CMAJ. 2007 Dec 4;177(12):1506-12
18056599
Pediatrics. 2009 Jun;123(6):1439-45
19482752
Ann Epidemiol. 2009 Aug;19(8):531-8
19394865
N Engl J Med. 2007 May 10;356(19):1915-27
17494925